Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 895 (LINC00895) is a long non-coding RNA (lncRNA) transcript that exceeds 200 nucleotides in length and does not overlap with protein-coding regions. Like other lincRNAs, it is transcribed by RNA polymerase II and does not encode a protein. LINC00895 is annotated in genomics databases and has alternative names AC000077.2 and AC000067.1. There is no evidence in current scientific databases of a direct involvement of LINC00895 as a therapeutic target, nor are there any drugs or biomarkers known to interact with it. The general class of lincRNAs is increasingly recognized for regulatory roles in gene expression and nervous system function but the specific biological functions and clinical roles of LINC00895 remain uncharacterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 895 (LINC00895).